Randomized phase II trial comparing molecularly targeted therapy based on tumor molecular profiling versus conventional therapy in patients with refractory cancer: cross-over analysis from the SHIVA trial

Auteurs

L. Belin, M. Kamal, C. Mauborgne, C. Plancher, F. Mulot, J.-P. Delord, A. Gonçalves, C. Gavoille, C. Dubot, N. Isambert, M. Campone, O. Trédan, F. Ricci, M. Alt, D. Loirat, M.-P. Sablin, X. Paoletti, V. Servois, C. Le Tourneau